Research ArticleArticle
Can the Cancer-related Fatigue Case-definition Criteria Be Applied to Chronic Medical Illness? A Comparison between Breast Cancer and Systemic Sclerosis
Linda Kwakkenbos, Ollie Minton, Patrick C. Stone, Susanna Alexander, Murray Baron, Marie Hudson and Brett D. Thombs
The Journal of Rheumatology June 2015, jrheum.141421; DOI: https://doi.org/10.3899/jrheum.141421
Linda Kwakkenbos
From the Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Division of Population Health Sciences and Education, St. Georges University of London; Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; Norfolk and Norwich University Hospitals National Health Service (NHS) Foundation Trust, Norwich, UK. Supported by Cancer Research UK (Grant #C11075/A7143 and C31193/ A10090), an American College of Rheumatology Research and Education Foundation Health Professional Investigator Award, and grants from the Fonds de la Recherche en Santé du Québec (dossier #14409) and the Canadian Institutes of Health Research (CIHR; grant #TR3-267681). The Canadian Scleroderma Research Group (CSRG) has been funded by the CIHR (grant #FRN 83518), the Scleroderma Society of Canada and its provincial chapters (Scleroderma Society of Ontario, Sclérodermie Québec), Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, California, USA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Fonds de la recherche en santé du Québec (FRSQ), the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, Quebec, Canada. The CSRG has also received educational grants from Pfizer and Actelion pharmaceutical companies. Dr. Kwakkenbos was supported by a Fonds de Recherche du Québec - Santé (FRQS) postdoctoral fellowship. Dr. Hudson was supported by an FRQS Clinical Research Scholar award. Dr. Thombs was supported by an Investigator Salary Award from the Arthritis Society. L. Kwakkenbos, PhD, Department of Psychiatry, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital; O. Minton, PhD, Division of Population Health Sciences and Education, St. Georges University of London; P.C. Stone, MD, Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; S. Alexander, PhD, Norfolk and Norwich University Hospitals NHS Foundation Trust; M. Baron, MD; M. Hudson, MD, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University; B.D. Thombs, PhD, Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. L. Kwakkenbos, Jewish General Hospital, 4333 Cote Ste. Catherine Road, Montreal, Quebec H3T 1E4, Canada. E-mail: kwakkenbosL@gmail.com Accepted for publication March 18, 2015.
Ollie Minton
From the Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Division of Population Health Sciences and Education, St. Georges University of London; Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; Norfolk and Norwich University Hospitals National Health Service (NHS) Foundation Trust, Norwich, UK. Supported by Cancer Research UK (Grant #C11075/A7143 and C31193/ A10090), an American College of Rheumatology Research and Education Foundation Health Professional Investigator Award, and grants from the Fonds de la Recherche en Santé du Québec (dossier #14409) and the Canadian Institutes of Health Research (CIHR; grant #TR3-267681). The Canadian Scleroderma Research Group (CSRG) has been funded by the CIHR (grant #FRN 83518), the Scleroderma Society of Canada and its provincial chapters (Scleroderma Society of Ontario, Sclérodermie Québec), Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, California, USA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Fonds de la recherche en santé du Québec (FRSQ), the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, Quebec, Canada. The CSRG has also received educational grants from Pfizer and Actelion pharmaceutical companies. Dr. Kwakkenbos was supported by a Fonds de Recherche du Québec - Santé (FRQS) postdoctoral fellowship. Dr. Hudson was supported by an FRQS Clinical Research Scholar award. Dr. Thombs was supported by an Investigator Salary Award from the Arthritis Society. L. Kwakkenbos, PhD, Department of Psychiatry, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital; O. Minton, PhD, Division of Population Health Sciences and Education, St. Georges University of London; P.C. Stone, MD, Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; S. Alexander, PhD, Norfolk and Norwich University Hospitals NHS Foundation Trust; M. Baron, MD; M. Hudson, MD, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University; B.D. Thombs, PhD, Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. L. Kwakkenbos, Jewish General Hospital, 4333 Cote Ste. Catherine Road, Montreal, Quebec H3T 1E4, Canada. E-mail: kwakkenbosL@gmail.com Accepted for publication March 18, 2015.
Patrick C. Stone
From the Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Division of Population Health Sciences and Education, St. Georges University of London; Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; Norfolk and Norwich University Hospitals National Health Service (NHS) Foundation Trust, Norwich, UK. Supported by Cancer Research UK (Grant #C11075/A7143 and C31193/ A10090), an American College of Rheumatology Research and Education Foundation Health Professional Investigator Award, and grants from the Fonds de la Recherche en Santé du Québec (dossier #14409) and the Canadian Institutes of Health Research (CIHR; grant #TR3-267681). The Canadian Scleroderma Research Group (CSRG) has been funded by the CIHR (grant #FRN 83518), the Scleroderma Society of Canada and its provincial chapters (Scleroderma Society of Ontario, Sclérodermie Québec), Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, California, USA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Fonds de la recherche en santé du Québec (FRSQ), the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, Quebec, Canada. The CSRG has also received educational grants from Pfizer and Actelion pharmaceutical companies. Dr. Kwakkenbos was supported by a Fonds de Recherche du Québec - Santé (FRQS) postdoctoral fellowship. Dr. Hudson was supported by an FRQS Clinical Research Scholar award. Dr. Thombs was supported by an Investigator Salary Award from the Arthritis Society. L. Kwakkenbos, PhD, Department of Psychiatry, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital; O. Minton, PhD, Division of Population Health Sciences and Education, St. Georges University of London; P.C. Stone, MD, Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; S. Alexander, PhD, Norfolk and Norwich University Hospitals NHS Foundation Trust; M. Baron, MD; M. Hudson, MD, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University; B.D. Thombs, PhD, Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. L. Kwakkenbos, Jewish General Hospital, 4333 Cote Ste. Catherine Road, Montreal, Quebec H3T 1E4, Canada. E-mail: kwakkenbosL@gmail.com Accepted for publication March 18, 2015.
Susanna Alexander
From the Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Division of Population Health Sciences and Education, St. Georges University of London; Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; Norfolk and Norwich University Hospitals National Health Service (NHS) Foundation Trust, Norwich, UK. Supported by Cancer Research UK (Grant #C11075/A7143 and C31193/ A10090), an American College of Rheumatology Research and Education Foundation Health Professional Investigator Award, and grants from the Fonds de la Recherche en Santé du Québec (dossier #14409) and the Canadian Institutes of Health Research (CIHR; grant #TR3-267681). The Canadian Scleroderma Research Group (CSRG) has been funded by the CIHR (grant #FRN 83518), the Scleroderma Society of Canada and its provincial chapters (Scleroderma Society of Ontario, Sclérodermie Québec), Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, California, USA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Fonds de la recherche en santé du Québec (FRSQ), the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, Quebec, Canada. The CSRG has also received educational grants from Pfizer and Actelion pharmaceutical companies. Dr. Kwakkenbos was supported by a Fonds de Recherche du Québec - Santé (FRQS) postdoctoral fellowship. Dr. Hudson was supported by an FRQS Clinical Research Scholar award. Dr. Thombs was supported by an Investigator Salary Award from the Arthritis Society. L. Kwakkenbos, PhD, Department of Psychiatry, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital; O. Minton, PhD, Division of Population Health Sciences and Education, St. Georges University of London; P.C. Stone, MD, Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; S. Alexander, PhD, Norfolk and Norwich University Hospitals NHS Foundation Trust; M. Baron, MD; M. Hudson, MD, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University; B.D. Thombs, PhD, Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. L. Kwakkenbos, Jewish General Hospital, 4333 Cote Ste. Catherine Road, Montreal, Quebec H3T 1E4, Canada. E-mail: kwakkenbosL@gmail.com Accepted for publication March 18, 2015.
Murray Baron
From the Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Division of Population Health Sciences and Education, St. Georges University of London; Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; Norfolk and Norwich University Hospitals National Health Service (NHS) Foundation Trust, Norwich, UK. Supported by Cancer Research UK (Grant #C11075/A7143 and C31193/ A10090), an American College of Rheumatology Research and Education Foundation Health Professional Investigator Award, and grants from the Fonds de la Recherche en Santé du Québec (dossier #14409) and the Canadian Institutes of Health Research (CIHR; grant #TR3-267681). The Canadian Scleroderma Research Group (CSRG) has been funded by the CIHR (grant #FRN 83518), the Scleroderma Society of Canada and its provincial chapters (Scleroderma Society of Ontario, Sclérodermie Québec), Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, California, USA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Fonds de la recherche en santé du Québec (FRSQ), the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, Quebec, Canada. The CSRG has also received educational grants from Pfizer and Actelion pharmaceutical companies. Dr. Kwakkenbos was supported by a Fonds de Recherche du Québec - Santé (FRQS) postdoctoral fellowship. Dr. Hudson was supported by an FRQS Clinical Research Scholar award. Dr. Thombs was supported by an Investigator Salary Award from the Arthritis Society. L. Kwakkenbos, PhD, Department of Psychiatry, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital; O. Minton, PhD, Division of Population Health Sciences and Education, St. Georges University of London; P.C. Stone, MD, Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; S. Alexander, PhD, Norfolk and Norwich University Hospitals NHS Foundation Trust; M. Baron, MD; M. Hudson, MD, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University; B.D. Thombs, PhD, Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. L. Kwakkenbos, Jewish General Hospital, 4333 Cote Ste. Catherine Road, Montreal, Quebec H3T 1E4, Canada. E-mail: kwakkenbosL@gmail.com Accepted for publication March 18, 2015.
Marie Hudson
From the Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Division of Population Health Sciences and Education, St. Georges University of London; Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; Norfolk and Norwich University Hospitals National Health Service (NHS) Foundation Trust, Norwich, UK. Supported by Cancer Research UK (Grant #C11075/A7143 and C31193/ A10090), an American College of Rheumatology Research and Education Foundation Health Professional Investigator Award, and grants from the Fonds de la Recherche en Santé du Québec (dossier #14409) and the Canadian Institutes of Health Research (CIHR; grant #TR3-267681). The Canadian Scleroderma Research Group (CSRG) has been funded by the CIHR (grant #FRN 83518), the Scleroderma Society of Canada and its provincial chapters (Scleroderma Society of Ontario, Sclérodermie Québec), Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, California, USA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Fonds de la recherche en santé du Québec (FRSQ), the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, Quebec, Canada. The CSRG has also received educational grants from Pfizer and Actelion pharmaceutical companies. Dr. Kwakkenbos was supported by a Fonds de Recherche du Québec - Santé (FRQS) postdoctoral fellowship. Dr. Hudson was supported by an FRQS Clinical Research Scholar award. Dr. Thombs was supported by an Investigator Salary Award from the Arthritis Society. L. Kwakkenbos, PhD, Department of Psychiatry, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital; O. Minton, PhD, Division of Population Health Sciences and Education, St. Georges University of London; P.C. Stone, MD, Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; S. Alexander, PhD, Norfolk and Norwich University Hospitals NHS Foundation Trust; M. Baron, MD; M. Hudson, MD, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University; B.D. Thombs, PhD, Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. L. Kwakkenbos, Jewish General Hospital, 4333 Cote Ste. Catherine Road, Montreal, Quebec H3T 1E4, Canada. E-mail: kwakkenbosL@gmail.com Accepted for publication March 18, 2015.
Brett D. Thombs
From the Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Division of Population Health Sciences and Education, St. Georges University of London; Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; Norfolk and Norwich University Hospitals National Health Service (NHS) Foundation Trust, Norwich, UK. Supported by Cancer Research UK (Grant #C11075/A7143 and C31193/ A10090), an American College of Rheumatology Research and Education Foundation Health Professional Investigator Award, and grants from the Fonds de la Recherche en Santé du Québec (dossier #14409) and the Canadian Institutes of Health Research (CIHR; grant #TR3-267681). The Canadian Scleroderma Research Group (CSRG) has been funded by the CIHR (grant #FRN 83518), the Scleroderma Society of Canada and its provincial chapters (Scleroderma Society of Ontario, Sclérodermie Québec), Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, California, USA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Fonds de la recherche en santé du Québec (FRSQ), the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, Quebec, Canada. The CSRG has also received educational grants from Pfizer and Actelion pharmaceutical companies. Dr. Kwakkenbos was supported by a Fonds de Recherche du Québec - Santé (FRQS) postdoctoral fellowship. Dr. Hudson was supported by an FRQS Clinical Research Scholar award. Dr. Thombs was supported by an Investigator Salary Award from the Arthritis Society. L. Kwakkenbos, PhD, Department of Psychiatry, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital; O. Minton, PhD, Division of Population Health Sciences and Education, St. Georges University of London; P.C. Stone, MD, Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London; S. Alexander, PhD, Norfolk and Norwich University Hospitals NHS Foundation Trust; M. Baron, MD; M. Hudson, MD, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University; B.D. Thombs, PhD, Department of Psychiatry, Department of Medicine, Department of Epidemiology, Biostatistics and Occupational Health, Department of Educational and Counselling Psychology, Department of Psychology, and School of Nursing, McGill University, and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. L. Kwakkenbos, Jewish General Hospital, 4333 Cote Ste. Catherine Road, Montreal, Quebec H3T 1E4, Canada. E-mail: kwakkenbosL@gmail.com Accepted for publication March 18, 2015.
Roles: the Canadian Scleroderma Research Group
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Can the Cancer-related Fatigue Case-definition Criteria Be Applied to Chronic Medical Illness? A Comparison between Breast Cancer and Systemic Sclerosis
Linda Kwakkenbos, Ollie Minton, Patrick C. Stone, Susanna Alexander, Murray Baron, Marie Hudson, Brett D. Thombs
The Journal of Rheumatology Jun 2015, jrheum.141421; DOI: 10.3899/jrheum.141421
Can the Cancer-related Fatigue Case-definition Criteria Be Applied to Chronic Medical Illness? A Comparison between Breast Cancer and Systemic Sclerosis
Linda Kwakkenbos, Ollie Minton, Patrick C. Stone, Susanna Alexander, Murray Baron, Marie Hudson, Brett D. Thombs
The Journal of Rheumatology Jun 2015, jrheum.141421; DOI: 10.3899/jrheum.141421